Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein–protein interaction

Approaches to understanding obstacles thought of as being specifically attached to PPIs, and existing techniques to combat these obstacles, were very helpful in overcoming them. The example of ABT-263 provides evidence that the larger family of PPI targets is more tractable than may have been thought.